Igm Biosciences Inc (IGMS) Annual Balance Sheets

Annual · GAAP · USD millions
Access IGMS quarterly Balance Sheets →
The table below presents a historical view of Igm Biosciences Inc's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent26.50
Combined Cash+Investments Total (filer-reported)183.80
Marketable Securities, Total MA157.29
Cash & Short-term Investments183.00
Other Current Assets0.17
Prepaid Expense And Other Assets Current9.67
Total Current Assets193.62
Equipment/Property/Plant Net32.51
Other Assets, Noncurrent2.00
Restricted Cash0.17
Operating Lease Right Of Use Asset38.52
Total Assets265.71
Liabilities
Accounts Payable, Current AC0.98
Accrued Liabilities, Current AC26.88
Other Liabilities, Current9.77
Total Current Liabilities37.64
Total Long-term Debt0.00
Other liabilities, Noncurrent179.90
OperatingLeaseLiabilityNoncurrent38.07
Operating Lease Liability Current7.12
Total Liabilities217.54
Stockholders' Equity
Common Stock Value0.34
Additional Paid In Capital Common Stock1,064.45
Retained Earnings / Accumulated Deficit-1,017.04
Other Equity0.41
Common Stockholder's Equity48.17
Total Stockholder's Equity48.17
Liabilities & Stockholder's Equity265.71
4 historic quarters locked

Sign in to unlock the full Igm Biosciences Inc balance sheet history.

About Igm Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-034597

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.